CETP and cardiovascular disorder: However, it is not known whether inhibition of CETP activity can prevent cardiovascular disease because four CETP inhibitors (torcetrapib, dalcetrapib, evacetrapib, and anacetrapib) failed to prove their efficacy in terms of reduction of cardiovascular risk by clinical trials(https://en.wikipedia.org/wiki/CETP_inhibitor).